New pill could help millions with stubborn high cholesterol
NCT ID NCT07623915
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests bempedoic acid, a daily pill, in 222 adults with high cholesterol that statins alone can't control. Participants take the drug or a placebo for 12 weeks while staying on their usual cholesterol meds. The main goal is to see how much LDL ('bad') cholesterol drops. If successful, it could provide a new option for people at risk of heart disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bempedoic acid
- What this could lead to
- If it works, this could offer a new daily pill option for people with high cholesterol that statins alone can't manage.
- What could go wrong
- This is still a phase 3 trial, so results are not yet known. The drug may not lower cholesterol enough or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two experimental pills work together safely? a trial seeks answers
- Can a new pill tame high cholesterol? a phase 1 trial puts SAL0167 to the test
- Gut bacteria may tame pancreatitis — probiotic combo put to the test
- Fatty meals may trap vitamin e in the blood, study suggests
- Could vinegar and fasting fix prediabetes cholesterol?
- Could a monthly shot beat biweekly for lowering cholesterol?